DENTSPLY SIRONA Q2 EPS Estimate Lifted by Leerink Partnrs

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at Leerink Partnrs raised their Q2 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Monday, July 14th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will post earnings per share of $0.49 for the quarter, up from their prior estimate of $0.46. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s Q3 2025 earnings at $0.46 EPS, FY2025 earnings at $1.90 EPS, FY2026 earnings at $2.06 EPS and FY2027 earnings at $2.32 EPS.

XRAY has been the subject of a number of other reports. Morgan Stanley downgraded DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price objective for the company. in a research report on Tuesday, April 15th. Wall Street Zen raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Sunday. Barrington Research boosted their price objective on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Monday, May 12th. UBS Group lowered their price objective on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Finally, Piper Sandler lowered their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research report on Wednesday, April 30th. Eleven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $20.36.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $15.81 on Wednesday. DENTSPLY SIRONA has a one year low of $12.16 and a one year high of $27.95. The company has a market cap of $3.15 billion, a PE ratio of -3.48, a P/E/G ratio of 1.14 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The business has a 50-day simple moving average of $16.08 and a 200-day simple moving average of $16.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. DENTSPLY SIRONA’s revenue was down 7.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 EPS.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date was Friday, June 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.10%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Treasurer of the State of North Carolina increased its position in shares of DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock valued at $1,686,000 after acquiring an additional 560 shares during the last quarter. Quarry LP grew its holdings in shares of DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock valued at $72,000 after purchasing an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in shares of DENTSPLY SIRONA by 1.4% in the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after purchasing an additional 861 shares in the last quarter. Federated Hermes Inc. grew its holdings in shares of DENTSPLY SIRONA by 0.5% in the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock valued at $3,213,000 after purchasing an additional 915 shares in the last quarter. Finally, Gabelli Funds LLC grew its holdings in shares of DENTSPLY SIRONA by 1.0% in the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after purchasing an additional 1,000 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.